1. A Phase II Study to Assess the Safety and Efficacy of the Dual mTORC1/2 and PI3K Inhibitor Bimiralisib (PQR309) in Relapsed, Refractory Lymphoma. Issue 11 (27th November 2021) Authors: Collins, Graham P.; Eyre, Toby A.; Schmitz-Rohmer, Debora; Townsend, William; Popat, Rakesh; Giulino-Roth, Lisa; Fields, Paul A.; Krasniqi, Fatime; Soussain, Carole; Stathis, Anastasios; Andjelkovic, Nebojsa; Cunningham, David; Mandic, Danijela; Radulovic, Sinisa; Tijanic, Ivan; Horowitz, Netanel... Journal: HemaSphere Issue: Volume 5:Issue 11(2021) Page Start: e656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute myeloid leukemia during pregnancy: a systematic review and meta-analysis. Issue 3 (4th March 2018) Authors: Horowitz, Netanel A.; Henig, Israel; Henig, Oryan; Benyamini, Noam; Vidal, Liat; Avivi, Irit Journal: Leukemia & lymphoma Issue: Volume 59:Issue 3(2018) Page Start: 610 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Addition of high-dose methotrexate to standard treatment for patients with high-risk diffuse large B-cell lymphoma contributes to improved freedom from progression and survival but does not prevent central nervous system relapse. Issue 8 (3rd July 2019) Authors: Goldschmidt, Neta; Horowitz, Netanel A.; Heffes, Vered; Darawshy, Fares; Mashiach, Tatiana; Shaulov, Adir; Gatt, Moshe E.; Dann, Eldad J. Journal: Leukemia & lymphoma Issue: Volume 60:Issue 8(2019) Page Start: 1890 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Advances in BCR/ABL positive ALL. Issue 3 (13th May 2019) Authors: Horowitz, Netanel A.; Rowe, Jacob M. Journal: Advances in cell and gene therapy Issue: Volume 2:Issue 3(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Advances in the genetics of acute lymphoblastic leukemia in adults and the potential clinical implications. Issue 10 (3rd October 2018) Authors: Horowitz, Netanel A.; Akasha, Doaa; Rowe, Jacob M. Journal: Expert review of hematology Issue: Volume 11:Issue 10(2018) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Association between IgG antibody levels and adverse events after first and second Bnt162b2 mRNA vaccine doses. (December 2022) Authors: Braun, Eyal; Horowitz, Netanel A.; Leiba, Ronit; Weissman, Avi; Mekel, Michal; Shachor-Meyouhas, Yael; Hussein, Khetam; Halberthal, Michael; Azzam, Zaher S.; Berger, Gidon Journal: Clinical microbiology and infection Issue: Volume 28:Number 12(2022) Page Start: 1644 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Attenuated humoral immune response following anti‐SARS‐CoV‐2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis. Issue 12 (16th October 2021) Authors: Schiller Salton, Neta; Szwarcwort, Moran; Tzoran, Inna; Horowitz, Netanel A.; Zuckerman, Tsila; Horesh, Nurit; Shachor‐Meyouhas, Yael; Hussein, Khetam; Lavi, Noa Journal: American journal of hematology Issue: Volume 96:Issue 12(2021) Page Start: E475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine‐induced peripheral neuropathy in patients with lymphoma. (25th June 2018) Authors: Azoulay, David; Nasser, Roni; Sharon, Rivka; Simanovich, Liya; Akria, Luiza; Shaoul, Ety; Horowitz, Netanel A. Journal: British journal of haematology Issue: Volume 185:Number 1(2019) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Brain-derived neurotrophic factor in hematological malignancies: From detrimental to potentially beneficial. (January 2022) Authors: Azoulay, David; Horowitz, Netanel A. Journal: Blood reviews Issue: Volume 51(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Brain‐derived neurotrophic factor as a potential biomarker of chemotherapy‐induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization. (18th June 2020) Authors: Azoulay, David; Horowitz, Netanel A. Journal: British journal of haematology Issue: Volume 191:Number 1(2020) Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗